Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 3/20 | 0.67 |
| ▸ | RAB9A | P51151 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | CHKA | P35790 | 1/20 | 0.65 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29475563 | 0.97 | ALDH1A1 (0.71) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL6887590 | 0.97 | ALDH1A1 (0.71) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL28356161 | 0.93 | ALDH1A1 (0.59) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL11548897 | 0.91 | ALDH1A1 (0.58) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL31013493 | 0.88 | ALDH1A1 (0.62) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL2175616 | 0.86 | LMNA (0.62) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL657027 | 0.86 | ALDH1A1 (0.57) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL327765 | 0.86 | ADRB1 (0.64) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL21565473 | 0.86 | ALDH1A1 (0.54) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 | |
| SCHEMBL21450824 | 0.86 | ALDH1A1 (0.54) | ALDH1A1MAPTL3MBTL1KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111057059-B | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2022-04-26 | — | — | CN | claimed |
| CN-111057059-A | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2020-04-24 | — | — | CN | claimed |
| CN-113646899-B | n-type semiconductor element, method for manufacturing n-type semiconductor element, wireless communication device, and commodity tag | 东丽株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-111057059-B | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2022-04-26 | — | — | CN | disclosed |
| CN-111057059-B | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2022-04-26 | — | — | CN | disclosed |
| CN-111057059-A | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2020-04-24 | — | — | CN | disclosed |
| CN-111057059-A | Benzodithiepyrrole compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2020-04-24 | — | — | CN | disclosed |
| US-9440958-B2 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | INCYTE CORPORATION (US) | 2016-09-13 | — | — | US | disclosed |
| US-20150025056-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | INCYTE CORPORATION (US) | 2015-01-22 | — | — | US | disclosed |
| US-7973041-B2 | Antiarthritic agents; psoriasis; anticancer agents;antiallergens; metalloprotease inhibitors. | INCYTE CORPORATION (US) | 2011-07-05 | — | — | US | disclosed |
| US-7491724-B2 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | INCYTE CORPORATION (US) | 2009-02-17 | — | — | US | disclosed |
| EP-0012908-A2 | Photographic colour diffusion transfer process and photographic recording material suitable therefor | Agfa-Gevaert AG (DE) | 1980-07-09 | — | — | EP | disclosed |
| US-4198235-A | Dye diffusion transfer process employing compounds that release sulfonamide dye providing radicals | AGFA-GEVAERT, A.G. (DE) | 1980-04-15 | — | — | US | disclosed |
| US-4195992-A | AZO DYE | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | disclosed |
| US-4179291-A | SILVER HALIDE EMULSION WITH A NON-DIFFUSIBLE DYE PRODUCING COMPOUND | AGFA-GEVAERT, A.G. (DE) | 1979-12-18 | — | — | US | disclosed |
| US-4171220-A | Photographic dye diffusion transfer process | AGFA-GEVAERT, A.G. (DE) | 1979-10-16 | — | — | US | disclosed |
| EP-0004400-A2 | Photographic diffusion transfer process and material for the production of colour images and suitable compounds therefor | AGFA-GEVAERT N.V. (BE) | 1979-10-03 | — | — | EP | disclosed |
| EP-0003581-A2 | Photographic colour diffusion transfer process | Agfa-Gevaert AG (DE) | 1979-08-22 | — | — | EP | disclosed |
| US-4139383-A | Dye diffusion transfer employing pyridine azo dye | AGFA-GEVAERT AG (DE) | 1979-02-13 | — | — | US | disclosed |
| EP-0000511-A1 | Photographic colour diffusion transfer process | Agfa-Gevaert AG (DE) | 1979-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025056-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | MMP25, MMP2, MMP14 | ALDH1A1 497/4885MAPT 2732/4885L3MBTL1 3117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.